当前位置:首页 - 行情中心 - 仁和药业(000650) - 财务分析 - 现金流量表

仁和药业

(000650)

  

流通市值:68.97亿  总市值:72.52亿
流通股本:13.31亿   总股本:14.00亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,158,782,109.89893,568,477.914,231,975,509.283,183,899,963.58
  收到的税费返还4,713,123.951,633.95-9,566.87
  收到其他与经营活动有关的现金18,574,637.4811,674,394.66114,386,672.14152,493,969.37
  经营活动现金流入小计2,182,069,871.32905,244,506.524,346,362,181.423,336,403,499.82
  购买商品、接受劳务支付的现金1,044,523,732.86530,025,908.332,461,083,405.581,641,990,931.59
  支付给职工以及为职工支付的现金264,223,146.14160,636,569.49497,902,079.93373,423,486.14
  支付的各项税费205,843,720.4643,659,264.25354,244,479.95236,942,118.38
  支付其他与经营活动有关的现金95,055,092.3746,369,106.83181,820,216.06243,562,700.58
  经营活动现金流出小计1,609,645,691.83780,690,848.93,495,050,181.522,495,919,236.69
  经营活动产生的现金流量净额572,424,179.49124,553,657.62851,311,999.9840,484,263.13
二、投资活动产生的现金流量:
  收回投资收到的现金5,315,827,758.952,849,258,339.0711,834,967,400.686,501,596,227.45
  取得投资收益收到的现金34,919,733.4119,078,949.78114,414,815.2159,326,090.03
  处置固定资产、无形资产和其他长期资产收回的现金净额5,763.275,750360,236.15220,071.85
  投资活动现金流入小计5,350,753,255.632,868,343,038.8511,949,742,452.046,561,142,389.33
  购建固定资产、无形资产和其他长期资产支付的现金21,048,483.1418,641,157.8674,587,219.1356,124,503.12
  投资支付的现金7,243,952,234.164,737,531,289.4511,973,376,888.598,357,743,246.23
  取得子公司及其他营业单位支付的现金0-63,489.2695,461.9
  投资活动现金流出小计7,265,000,717.34,756,172,447.3112,048,027,596.988,413,963,211.25
  投资活动产生的现金流量净额-1,914,247,461.67-1,887,829,408.46-98,285,144.94-1,852,820,821.92
三、筹资活动产生的现金流量:
  吸收投资收到的现金-080,00080,000
  其中:子公司吸收少数股东投资收到的现金-080,00080,000
  取得借款收到的现金-0--
  收到其他与筹资活动有关的现金-02,325,000-
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-02,405,00080,000
  偿还债务支付的现金-0--
  分配股利、利润或偿付利息支付的现金1,382,665.910306,106,206.24238,342,279.2
  其中:子公司支付给少数股东的股利、利润1,382,665.91095,623,262.8428,351,544.1
  支付其他与筹资活动有关的现金95,239,885.470918,992.42-
  筹资活动现金流出小计96,622,551.380307,025,198.66238,342,279.2
  筹资活动产生的现金流量净额-96,622,551.380-304,620,198.66-238,262,279.2
四、汇率变动对现金及现金等价物的影响-35,537.68-20,777.29-9,950.5-
五、现金及现金等价物净增加额-1,438,481,371.24-1,763,296,528.13448,396,705.8-1,250,598,837.99
  加:期初现金及现金等价物余额2,773,961,378.542,773,961,378.542,325,564,672.742,325,564,672.74
  期末现金及现金等价物余额1,335,480,007.31,010,664,850.412,773,961,378.541,074,965,834.75
补充资料:
  净利润355,382,564.49-487,656,749.45-
  资产减值准备169,209.19-129,175,268.45-
  固定资产和投资性房地产折旧51,283,671.73-100,603,259.87-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧51,283,671.73-100,603,259.87-
  无形资产摊销6,902,360.36-14,615,618.05-
  长期待摊费用摊销1,070,710.34-3,372,841.37-
  处置固定资产、无形资产和其他长期资产的损失41,579.62--2,048,182.02-
  固定资产报废损失4,615.67-407,460.75-
  公允价值变动损失-29,539,733.37--25,116,621.86-
  财务费用35,006.92-90,869.76-
  投资损失-15,330,658.7--83,430,024.12-
  递延所得税3,175,494.95-306,297.07-
  其中:递延所得税资产减少3,186,325.88-410,567.3-
    递延所得税负债增加-10,830.93--104,270.23-
  存货的减少222,685,123.8--49,230,030.81-
  经营性应收项目的减少-177,281,129.26-178,959,085.45-
  经营性应付项目的增加145,766,640.12-78,307,579.87-
  其他0--15,529,062.5-
  现金的期末余额1,335,480,007.3-2,773,961,378.54-
  减:现金的期初余额2,773,961,378.54-2,325,564,672.74-
  现金及现金等价物的净增加额-1,438,481,371.24-448,396,705.8-
公告日期2026-08-262026-04-282026-04-242025-10-31
审计意见(境内)标准无保留意见
TOP↑